Castle Biosciences, Inc. · NASDAQ:CSTL

Maetzold Derek J sold 3,338 Castle Biosciences, Inc. shares (Form 4)

Traded Apr 21, 2026 · Filed Apr 23, 2026

On Apr 21, 2026, Maetzold Derek J (Director, Pres. & Chief Exec. Officer) sold 3,338 Castle Biosciences, Inc. shares at US$25.10 for US$83,784 under a trading plan, leaving 2,502 shares. Filed Apr 23, 2026 (Form 4).

Sold
3,338 shares
Price
US$25.10
Value
US$83,784
Holding after
2,502 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Pres. & Chief Exec. Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 21, 2026Common StockOption exercise550US$2.3922,029Direct
Apr 21, 2026Common StockSale550US$25.1021,479Direct
Apr 21, 2026Common StockSale1,357US$25.1047,495Indirect
Apr 21, 2026Common StockSale1,153US$25.1040,367Indirect
Apr 21, 2026Common StockSale278US$25.102,502Indirect

Source

View original at SEC

Related